Early results suggest participant diversity and novel measures will enable new, artificial intelligence-driven insights. As ...

In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in ...

A study by a team of Chinese researchers highlights the potential of optical coherence tomography angiography (OCTA) in ...

ABI-110 has the potential to offer a durable and effective solution by addressing the root causes of wet AMD at the genetic ...

Differentiating hereditary from nonhereditary retinoblastoma is now possible overnight, improving early intervention ...

Special circumstances must be considered for plateau dwellers, such as Tibetans, mountaineers, and garrison officers, who are ...

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

Key findings include reduced lesion growth, retinal tissue preservation, and improved visual function, demonstrating ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...

MELT-300, a non-IV, non-opioid sedation tablet, showed positive Phase 3 results for cataract surgery, supporting FDA ...